United States · FDA National Drug Code directory
Fexofenadine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-782_c5d24cd6-8212-e647-78b1-27906e6f62bd
- Product NDC
- 55111-782
- Form
- TABLET
- Composition / generic term
- Fexofenadine hydrochloride
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110103
- Source listing expiry
- 20271231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (55111-782-01) · 55111-782-01
- 30 TABLET in 1 BOTTLE (55111-782-30) · 55111-782-30
- 10 BLISTER PACK in 1 CARTON (55111-782-78) / 10 TABLET in 1 BLISTER PACK (55111-782-79) · 55111-782-78
- 90 TABLET in 1 BOTTLE (55111-782-90) · 55111-782-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →